

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H4-K12 acetylation (GO:0043983) | 4.95187019 |
| 2 | adenosine metabolic process (GO:0046085) | 3.85319000 |
| 3 | fatty acid elongation (GO:0030497) | 3.77510524 |
| 4 | macroautophagy (GO:0016236) | 3.68894255 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.65689474 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 3.65689474 |
| 7 | microglial cell activation (GO:0001774) | 3.63505746 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.57622633 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 3.57622633 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 3.53031838 |
| 11 | autophagic vacuole fusion (GO:0000046) | 3.48246659 |
| 12 | phagocytosis, engulfment (GO:0006911) | 3.47198541 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46176998 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46176998 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44604641 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40046288 |
| 17 | valine metabolic process (GO:0006573) | 3.38243961 |
| 18 | regulation of sequestering of triglyceride (GO:0010889) | 3.35069895 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30526147 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 3.24131816 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13284479 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.13284479 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09239262 |
| 24 | cysteine metabolic process (GO:0006534) | 3.08725856 |
| 25 | intra-S DNA damage checkpoint (GO:0031573) | 3.04987115 |
| 26 | fatty acid beta-oxidation (GO:0006635) | 3.02468681 |
| 27 | regulation of plasminogen activation (GO:0010755) | 3.01165558 |
| 28 | complement activation, alternative pathway (GO:0006957) | 2.97407992 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 2.95929661 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 2.95531203 |
| 31 | inner ear receptor cell development (GO:0060119) | 2.94113743 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 2.91882591 |
| 33 | skeletal muscle tissue regeneration (GO:0043403) | 2.91707651 |
| 34 | fatty acid oxidation (GO:0019395) | 2.91408767 |
| 35 | signal peptide processing (GO:0006465) | 2.90934646 |
| 36 | organelle membrane fusion (GO:0090174) | 2.90843852 |
| 37 | carnitine metabolic process (GO:0009437) | 2.90702189 |
| 38 | glyoxylate metabolic process (GO:0046487) | 2.87882713 |
| 39 | lipid oxidation (GO:0034440) | 2.85483567 |
| 40 | tryptophan metabolic process (GO:0006568) | 2.85359732 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 2.84361284 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 2.84361284 |
| 43 | tryptophan catabolic process (GO:0006569) | 2.84361284 |
| 44 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82949028 |
| 45 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82949028 |
| 46 | retinol metabolic process (GO:0042572) | 2.82843249 |
| 47 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.82245939 |
| 48 | aldehyde catabolic process (GO:0046185) | 2.80573096 |
| 49 | cellular glucuronidation (GO:0052695) | 2.79876379 |
| 50 | alpha-linolenic acid metabolic process (GO:0036109) | 2.79685954 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 2.78490462 |
| 52 | negative regulation of gene silencing (GO:0060969) | 2.76073821 |
| 53 | glucuronate metabolic process (GO:0019585) | 2.75866161 |
| 54 | uronic acid metabolic process (GO:0006063) | 2.75866161 |
| 55 | protein carboxylation (GO:0018214) | 2.74441853 |
| 56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.74441853 |
| 57 | bile acid biosynthetic process (GO:0006699) | 2.73644262 |
| 58 | response to nitrosative stress (GO:0051409) | 2.73159506 |
| 59 | chemokine-mediated signaling pathway (GO:0070098) | 2.72891380 |
| 60 | cellular extravasation (GO:0045123) | 2.72819577 |
| 61 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.71407089 |
| 62 | regulation of cholesterol storage (GO:0010885) | 2.68584719 |
| 63 | white fat cell differentiation (GO:0050872) | 2.68001528 |
| 64 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.67011470 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 2.66300235 |
| 66 | membrane invagination (GO:0010324) | 2.66269949 |
| 67 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.65806124 |
| 68 | regulation of germinal center formation (GO:0002634) | 2.63962478 |
| 69 | response to interferon-beta (GO:0035456) | 2.63423263 |
| 70 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.63151126 |
| 71 | homocysteine metabolic process (GO:0050667) | 2.62617716 |
| 72 | positive regulation of interferon-alpha production (GO:0032727) | 2.62277662 |
| 73 | phospholipid efflux (GO:0033700) | 2.62227557 |
| 74 | response to lipoprotein particle (GO:0055094) | 2.59124030 |
| 75 | fatty acid catabolic process (GO:0009062) | 2.58799941 |
| 76 | low-density lipoprotein particle clearance (GO:0034383) | 2.58501644 |
| 77 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.58061820 |
| 78 | acylglycerol homeostasis (GO:0055090) | 2.57442635 |
| 79 | triglyceride homeostasis (GO:0070328) | 2.57442635 |
| 80 | cellular response to interferon-beta (GO:0035458) | 2.57226770 |
| 81 | urea metabolic process (GO:0019627) | 2.56229127 |
| 82 | urea cycle (GO:0000050) | 2.56229127 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 2.56087493 |
| 84 | negative regulation of lipid storage (GO:0010888) | 2.54959836 |
| 85 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.54203008 |
| 86 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53656790 |
| 87 | regulation of extracellular matrix disassembly (GO:0010715) | 2.53355609 |
| 88 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.52474312 |
| 89 | regulation of endothelial cell differentiation (GO:0045601) | 2.45868514 |
| 90 | regulation of interferon-alpha production (GO:0032647) | 2.44871024 |
| 91 | ethanol oxidation (GO:0006069) | 2.43979334 |
| 92 | kynurenine metabolic process (GO:0070189) | 2.42976880 |
| 93 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.42204584 |
| 94 | plasma lipoprotein particle remodeling (GO:0034369) | 2.41190333 |
| 95 | protein-lipid complex remodeling (GO:0034368) | 2.41190333 |
| 96 | macromolecular complex remodeling (GO:0034367) | 2.41190333 |
| 97 | heme transport (GO:0015886) | 2.40606153 |
| 98 | adaptation of signaling pathway (GO:0023058) | 2.40393838 |
| 99 | bile acid metabolic process (GO:0008206) | 2.38663160 |
| 100 | positive regulation of fatty acid oxidation (GO:0046321) | 2.37839251 |
| 101 | high-density lipoprotein particle remodeling (GO:0034375) | 2.37469578 |
| 102 | cell migration involved in heart development (GO:0060973) | 2.37376142 |
| 103 | platelet dense granule organization (GO:0060155) | 2.36682227 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.36069692 |
| 105 | cellular response to zinc ion (GO:0071294) | 2.35651053 |
| 106 | positive regulation of protein autophosphorylation (GO:0031954) | 2.35648903 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 2.35301667 |
| 108 | nitrogen cycle metabolic process (GO:0071941) | 2.34650548 |
| 109 | tyrosine metabolic process (GO:0006570) | 2.34327780 |
| 110 | regulation of protein activation cascade (GO:2000257) | 2.34265827 |
| 111 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.33742101 |
| 112 | monocarboxylic acid catabolic process (GO:0072329) | 2.33555648 |
| 113 | response to type I interferon (GO:0034340) | 2.33466924 |
| 114 | cellular defense response (GO:0006968) | 2.33352270 |
| 115 | aromatic amino acid family metabolic process (GO:0009072) | 2.32790178 |
| 116 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.31681428 |
| 117 | xenobiotic catabolic process (GO:0042178) | 2.31658064 |
| 118 | neutrophil activation (GO:0042119) | 2.31603625 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.31015970 |
| 120 | cellular response to type I interferon (GO:0071357) | 2.31015970 |
| 121 | triglyceride catabolic process (GO:0019433) | 2.30622665 |
| 122 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.30594521 |
| 123 | drug transmembrane transport (GO:0006855) | 2.30484625 |
| 124 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.29944520 |
| 125 | negative regulation of fibrinolysis (GO:0051918) | 2.29492337 |
| 126 | response to xenobiotic stimulus (GO:0009410) | 2.28721161 |
| 127 | flavonoid metabolic process (GO:0009812) | 2.28579456 |
| 128 | regulation of cholesterol metabolic process (GO:0090181) | 2.28375446 |
| 129 | detection of calcium ion (GO:0005513) | 2.27890870 |
| 130 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.27492057 |
| 131 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.27461310 |
| 132 | regulation of mononuclear cell migration (GO:0071675) | 2.26934505 |
| 133 | regulation of vitamin metabolic process (GO:0030656) | 2.26616371 |
| 134 | branched-chain amino acid metabolic process (GO:0009081) | 2.26458735 |
| 135 | myoblast migration (GO:0051451) | 2.26411533 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 2.25032179 |
| 137 | lysine metabolic process (GO:0006553) | 2.24826688 |
| 138 | lysine catabolic process (GO:0006554) | 2.24826688 |
| 139 | positive regulation of lipid storage (GO:0010884) | 2.24621110 |
| 140 | hepatocyte apoptotic process (GO:0097284) | 2.24217504 |
| 141 | protein targeting to lysosome (GO:0006622) | 2.23463928 |
| 142 | establishment of protein localization to vacuole (GO:0072666) | 2.23463928 |
| 143 | protein targeting to vacuole (GO:0006623) | 2.23463928 |
| 144 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.23415041 |
| 145 | regulation of complement activation (GO:0030449) | 2.23360982 |
| 146 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.22953507 |
| 147 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.22953507 |
| 148 | myeloid cell activation involved in immune response (GO:0002275) | 2.22486028 |
| 149 | fibrinolysis (GO:0042730) | 2.22435667 |
| 150 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.22122890 |
| 151 | regulation of interleukin-8 secretion (GO:2000482) | 2.20421511 |
| 152 | reactive oxygen species biosynthetic process (GO:1903409) | 2.19953906 |
| 153 | regulation of regulatory T cell differentiation (GO:0045589) | 2.19937614 |
| 154 | interferon-gamma production (GO:0032609) | 2.18986607 |
| 155 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.18934078 |
| 156 | natural killer cell mediated immunity (GO:0002228) | 2.18934078 |
| 157 | amyloid precursor protein catabolic process (GO:0042987) | 2.18854519 |
| 158 | mitochondrial calcium ion transport (GO:0006851) | 2.18817081 |
| 159 | branched-chain amino acid catabolic process (GO:0009083) | 2.18319098 |
| 160 | primary alcohol metabolic process (GO:0034308) | 2.17440805 |
| 161 | cellular response to interleukin-15 (GO:0071350) | 2.16894496 |
| 162 | lipid storage (GO:0019915) | 2.16651574 |
| 163 | short-chain fatty acid metabolic process (GO:0046459) | 2.16607251 |
| 164 | bile acid and bile salt transport (GO:0015721) | 2.16572704 |
| 165 | reverse cholesterol transport (GO:0043691) | 2.16249612 |
| 166 | macrophage chemotaxis (GO:0048246) | 2.15827602 |
| 167 | regulation of fibroblast apoptotic process (GO:2000269) | 2.15759366 |
| 168 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.15622889 |
| 169 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.15474913 |
| 170 | defense response to Gram-negative bacterium (GO:0050829) | 2.15051615 |
| 171 | desmosome organization (GO:0002934) | 2.13665338 |
| 172 | dendritic cell migration (GO:0036336) | 2.12485680 |
| 173 | macrophage activation (GO:0042116) | 2.11860794 |
| 174 | negative regulation of anoikis (GO:2000811) | 2.10297156 |
| 175 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.07072813 |
| 176 | cellular response to gamma radiation (GO:0071480) | 2.06866205 |
| 177 | negative regulation of acute inflammatory response (GO:0002674) | 2.04179719 |
| 178 | histamine secretion (GO:0001821) | 2.03030151 |
| 179 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.02179595 |
| 180 | radial glial cell differentiation (GO:0060019) | 2.00701733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.14547870 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.51095940 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.15184694 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77947638 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.51342709 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.48664378 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.43976588 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14378236 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.05331278 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86600321 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84104168 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.76566460 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.75516659 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.67256836 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63814281 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63754908 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60134112 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.47104712 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26277319 |
| 20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23382468 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.22506572 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21756017 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.19852284 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.14592400 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.10549524 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10280187 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10234233 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99810881 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98225039 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97535452 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95367672 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79229400 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76182016 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75309312 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73710336 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72655171 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66792696 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65879377 |
| 39 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.65593887 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.65113313 |
| 41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.63487472 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63269169 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.59920251 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59451943 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.56565814 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53713599 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50837305 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49914608 |
| 49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.49219626 |
| 50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48851186 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45673716 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44834260 |
| 53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.44003640 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.43108073 |
| 55 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.42588650 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41331607 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41269281 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41156674 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39557902 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39281639 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37220723 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.36690620 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.36272906 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.35787931 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35659736 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35453328 |
| 67 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.34349952 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33557441 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33060091 |
| 70 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.33012170 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32366821 |
| 72 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.32007790 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31371451 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30649651 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29169006 |
| 76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28998440 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27698026 |
| 78 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.27190973 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25386882 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24891879 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24280562 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24229648 |
| 83 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22161406 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21517700 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21426279 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18438155 |
| 87 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.18175400 |
| 88 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18061066 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.17857065 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17468524 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16541815 |
| 92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14594761 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13811170 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13811170 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11094422 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10195649 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10049880 |
| 98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09765933 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09736826 |
| 100 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09304391 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09024356 |
| 102 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08566898 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08262595 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07422553 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07189508 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06970323 |
| 107 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06590567 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06090587 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05872688 |
| 110 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05593618 |
| 111 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03556004 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02972124 |
| 113 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02972124 |
| 114 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02718829 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02532500 |
| 116 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02194429 |
| 117 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01063364 |
| 118 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00950784 |
| 119 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00579892 |
| 120 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00400536 |
| 121 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.00234157 |
| 122 | MAF_26560356_Chip-Seq_TH1_Human | 0.99574942 |
| 123 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99436447 |
| 124 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.99086453 |
| 125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98685198 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98535642 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97473009 |
| 128 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97427602 |
| 129 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97427602 |
| 130 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97393638 |
| 131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96980367 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96937782 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.96806703 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96523837 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96450648 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 0.95822511 |
| 137 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95517933 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94998735 |
| 139 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94829493 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94555328 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94206504 |
| 142 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94121031 |
| 143 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93950774 |
| 144 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93806067 |
| 145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93442812 |
| 146 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93399968 |
| 147 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93399968 |
| 148 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93287876 |
| 149 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92578075 |
| 150 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92359010 |
| 151 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92346924 |
| 152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91566510 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91336826 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91336826 |
| 155 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91285220 |
| 156 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90471390 |
| 157 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89532756 |
| 158 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88979365 |
| 159 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.88443787 |
| 160 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87128050 |
| 161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.84485234 |
| 162 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83945810 |
| 163 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83501320 |
| 164 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82861177 |
| 165 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82259305 |
| 166 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80865091 |
| 167 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79661335 |
| 168 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79234901 |
| 169 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.78827758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.55756195 |
| 2 | MP0005360_urolithiasis | 3.24731164 |
| 3 | MP0003183_abnormal_peptide_metabolism | 2.96895504 |
| 4 | MP0005365_abnormal_bile_salt | 2.84104753 |
| 5 | MP0003195_calcinosis | 2.70251056 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.66146407 |
| 7 | MP0004883_abnormal_blood_vessel | 2.46129087 |
| 8 | MP0003724_increased_susceptibility_to | 2.29910446 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.27117929 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.12770231 |
| 11 | MP0003252_abnormal_bile_duct | 2.10126875 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.07438332 |
| 13 | MP0003436_decreased_susceptibility_to | 2.02687474 |
| 14 | MP0004043_abnormal_pH_regulation | 2.02413036 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 1.97984437 |
| 16 | MP0005164_abnormal_response_to | 1.96425860 |
| 17 | MP0000013_abnormal_adipose_tissue | 1.95514140 |
| 18 | MP0003186_abnormal_redox_activity | 1.86963130 |
| 19 | MP0009785_altered_susceptibility_to | 1.84400388 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.82391489 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.78236625 |
| 22 | MP0002166_altered_tumor_susceptibility | 1.71999671 |
| 23 | MP0003303_peritoneal_inflammation | 1.70974649 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.64582880 |
| 25 | MP0004885_abnormal_endolymph | 1.63023533 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.61345074 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.59936614 |
| 28 | MP0005367_renal/urinary_system_phenotyp | 1.58833882 |
| 29 | MP0000516_abnormal_urinary_system | 1.58833882 |
| 30 | MP0005670_abnormal_white_adipose | 1.58012566 |
| 31 | MP0000685_abnormal_immune_system | 1.57248942 |
| 32 | MP0009840_abnormal_foam_cell | 1.50816101 |
| 33 | MP0003045_fibrosis | 1.50279703 |
| 34 | MP0003279_aneurysm | 1.49657231 |
| 35 | MP0002419_abnormal_innate_immunity | 1.48284575 |
| 36 | MP0001666_abnormal_nutrient_absorption | 1.48017308 |
| 37 | MP0005025_abnormal_response_to | 1.47957236 |
| 38 | MP0000609_abnormal_liver_physiology | 1.45846496 |
| 39 | MP0005332_abnormal_amino_acid | 1.44136056 |
| 40 | MP0002132_abnormal_respiratory_system | 1.43638350 |
| 41 | MP0006054_spinal_hemorrhage | 1.42913689 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.40341971 |
| 43 | MP0005166_decreased_susceptibility_to | 1.40208509 |
| 44 | MP0003828_pulmonary_edema | 1.39300226 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.38919463 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.38919463 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.37874965 |
| 48 | MP0001790_abnormal_immune_system | 1.35542657 |
| 49 | MP0005387_immune_system_phenotype | 1.35542657 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.34723686 |
| 51 | MP0008469_abnormal_protein_level | 1.34108342 |
| 52 | MP0006082_CNS_inflammation | 1.33575230 |
| 53 | MP0005451_abnormal_body_composition | 1.33150021 |
| 54 | MP0005379_endocrine/exocrine_gland_phen | 1.33008570 |
| 55 | MP0002006_tumorigenesis | 1.32201257 |
| 56 | MP0008004_abnormal_stomach_pH | 1.30854017 |
| 57 | MP0001542_abnormal_bone_strength | 1.30474141 |
| 58 | MP0005319_abnormal_enzyme/_coenzyme | 1.27836359 |
| 59 | MP0009764_decreased_sensitivity_to | 1.27657604 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.26575604 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.25785586 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.25687043 |
| 63 | MP0005671_abnormal_response_to | 1.24014746 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.23530062 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.23472601 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.22591237 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.22177020 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.21765549 |
| 69 | MP0001800_abnormal_humoral_immune | 1.21250915 |
| 70 | MP0005595_abnormal_vascular_smooth | 1.20208816 |
| 71 | MP0004947_skin_inflammation | 1.20095966 |
| 72 | MP0009697_abnormal_copulation | 1.19250717 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.18565641 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.18523478 |
| 75 | MP0008438_abnormal_cutaneous_collagen | 1.16393183 |
| 76 | MP0002723_abnormal_immune_serum | 1.15408976 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.15175674 |
| 78 | MP0002168_other_aberrant_phenotype | 1.15098791 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.14642890 |
| 80 | MP0004084_abnormal_cardiac_muscle | 1.13727803 |
| 81 | MP0005275_abnormal_skin_tensile | 1.13479327 |
| 82 | MP0001853_heart_inflammation | 1.11915440 |
| 83 | MP0008260_abnormal_autophagy | 1.11150442 |
| 84 | MP0009763_increased_sensitivity_to | 1.09388766 |
| 85 | MP0000538_abnormal_urinary_bladder | 1.08732020 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 1.08135304 |
| 87 | MP0002405_respiratory_system_inflammati | 1.07232225 |
| 88 | MP0001958_emphysema | 1.06775219 |
| 89 | MP0002060_abnormal_skin_morphology | 1.05154819 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 1.05077824 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 1.04120137 |
| 92 | MP0000343_altered_response_to | 1.03307487 |
| 93 | MP0002971_abnormal_brown_adipose | 1.02013059 |
| 94 | MP0005083_abnormal_biliary_tract | 1.01901932 |
| 95 | MP0001819_abnormal_immune_cell | 1.01430238 |
| 96 | MP0002420_abnormal_adaptive_immunity | 1.01116166 |
| 97 | MP0001663_abnormal_digestive_system | 1.00318732 |
| 98 | MP0005408_hypopigmentation | 1.00139166 |
| 99 | MP0002254_reproductive_system_inflammat | 0.99274427 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.98208400 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.97274614 |
| 102 | MP0004130_abnormal_muscle_cell | 0.96629407 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.96040688 |
| 104 | MP0000598_abnormal_liver_morphology | 0.95031974 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94705288 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.93904918 |
| 107 | MP0002009_preneoplasia | 0.92789867 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.92672823 |
| 109 | MP0005023_abnormal_wound_healing | 0.90554879 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.90481481 |
| 111 | MP0005646_abnormal_pituitary_gland | 0.88895847 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.88853829 |
| 113 | MP0002796_impaired_skin_barrier | 0.88546398 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.88012551 |
| 115 | MP0001764_abnormal_homeostasis | 0.87361283 |
| 116 | MP0002653_abnormal_ependyma_morphology | 0.86890294 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.86263776 |
| 118 | MP0000465_gastrointestinal_hemorrhage | 0.84775057 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.83847957 |
| 120 | MP0000249_abnormal_blood_vessel | 0.83126152 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.82940833 |
| 122 | MP0004484_altered_response_of | 0.82883625 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.82841459 |
| 124 | MP0001915_intracranial_hemorrhage | 0.82744307 |
| 125 | MP0008872_abnormal_physiological_respon | 0.82446965 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.82016118 |
| 127 | MP0003690_abnormal_glial_cell | 0.81877909 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.81103203 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.80723562 |
| 130 | MP0002102_abnormal_ear_morphology | 0.80433898 |
| 131 | MP0000858_altered_metastatic_potential | 0.79717501 |
| 132 | MP0001216_abnormal_epidermal_layer | 0.79707595 |
| 133 | MP0005636_abnormal_mineral_homeostasis | 0.79659508 |
| 134 | MP0003868_abnormal_feces_composition | 0.76631600 |
| 135 | MP0000716_abnormal_immune_system | 0.76168024 |
| 136 | MP0001756_abnormal_urination | 0.75984755 |
| 137 | MP0002998_abnormal_bone_remodeling | 0.75309261 |
| 138 | MP0003656_abnormal_erythrocyte_physiolo | 0.74074867 |
| 139 | MP0002396_abnormal_hematopoietic_system | 0.72701522 |
| 140 | MP0005334_abnormal_fat_pad | 0.71913721 |
| 141 | MP0001873_stomach_inflammation | 0.70856750 |
| 142 | MP0002933_joint_inflammation | 0.70823795 |
| 143 | MP0001243_abnormal_dermal_layer | 0.70350113 |
| 144 | MP0005084_abnormal_gallbladder_morpholo | 0.69883781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.28849697 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.17490960 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 3.75433128 |
| 4 | Hematochezia (HP:0002573) | 3.71550306 |
| 5 | Xanthomatosis (HP:0000991) | 3.62461896 |
| 6 | Generalized aminoaciduria (HP:0002909) | 3.55870261 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.47008823 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.43814930 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.35592196 |
| 10 | Myocardial infarction (HP:0001658) | 3.32224478 |
| 11 | Renal cortical cysts (HP:0000803) | 3.23727435 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19752020 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.19585605 |
| 14 | Nausea (HP:0002018) | 3.14480755 |
| 15 | Constricted visual fields (HP:0001133) | 3.08185844 |
| 16 | Deep venous thrombosis (HP:0002625) | 3.07089819 |
| 17 | Complement deficiency (HP:0004431) | 3.06875245 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.05150355 |
| 19 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.03373176 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 3.01022792 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.00425502 |
| 22 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.00201319 |
| 23 | Abnormality of alanine metabolism (HP:0010916) | 3.00201319 |
| 24 | Hyperalaninemia (HP:0003348) | 3.00201319 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93664451 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.92734709 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 2.87602909 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.85311863 |
| 29 | Thyroiditis (HP:0100646) | 2.84637242 |
| 30 | Chronic sinusitis (HP:0011109) | 2.84354343 |
| 31 | Disinhibition (HP:0000734) | 2.82632526 |
| 32 | Chronic otitis media (HP:0000389) | 2.82009256 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.77318387 |
| 34 | Epidermoid cyst (HP:0200040) | 2.75947772 |
| 35 | Hyperammonemia (HP:0001987) | 2.71485932 |
| 36 | Hypobetalipoproteinemia (HP:0003563) | 2.68464532 |
| 37 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.67530048 |
| 38 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.67530048 |
| 39 | Joint hemorrhage (HP:0005261) | 2.66563203 |
| 40 | Ketosis (HP:0001946) | 2.65271518 |
| 41 | Fat malabsorption (HP:0002630) | 2.64604866 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 2.63609565 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63609565 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.61035279 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.60967160 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.60967160 |
| 47 | Oligomenorrhea (HP:0000876) | 2.59250291 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58836390 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.58580711 |
| 50 | Recurrent sinusitis (HP:0011108) | 2.57743851 |
| 51 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.57718113 |
| 52 | Increased corneal curvature (HP:0100692) | 2.53853550 |
| 53 | Keratoconus (HP:0000563) | 2.53853550 |
| 54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49530309 |
| 55 | T lymphocytopenia (HP:0005403) | 2.49434716 |
| 56 | Congenital sensorineural hearing impairment (HP:0008527) | 2.47197795 |
| 57 | Glucose intolerance (HP:0000833) | 2.47041469 |
| 58 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.45484829 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43990787 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43990787 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43990787 |
| 62 | Eosinophilia (HP:0001880) | 2.43787811 |
| 63 | Abnormality of complement system (HP:0005339) | 2.42348028 |
| 64 | Granulocytopenia (HP:0001913) | 2.41685644 |
| 65 | Leukocytosis (HP:0001974) | 2.40260359 |
| 66 | Microcytic anemia (HP:0001935) | 2.37712477 |
| 67 | Hyperglycinuria (HP:0003108) | 2.37593426 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.35887795 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.35781814 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.35458922 |
| 71 | Severe visual impairment (HP:0001141) | 2.35329531 |
| 72 | Vasculitis (HP:0002633) | 2.33652428 |
| 73 | Hypoalphalipoproteinemia (HP:0003233) | 2.30080418 |
| 74 | Beaking of vertebral bodies (HP:0004568) | 2.26144497 |
| 75 | Pancreatitis (HP:0001733) | 2.25274852 |
| 76 | Absent/shortened dynein arms (HP:0200106) | 2.23314429 |
| 77 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.23314429 |
| 78 | Abnormality of methionine metabolism (HP:0010901) | 2.23191402 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.23112874 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.22950674 |
| 81 | Steatorrhea (HP:0002570) | 2.22854914 |
| 82 | Hypoproteinemia (HP:0003075) | 2.22441975 |
| 83 | Abnormality of vitamin metabolism (HP:0100508) | 2.22432998 |
| 84 | Peritonitis (HP:0002586) | 2.21952722 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.20217672 |
| 86 | Abnormality of glycine metabolism (HP:0010895) | 2.20217672 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.20150202 |
| 88 | Ketoacidosis (HP:0001993) | 2.18988074 |
| 89 | Acanthocytosis (HP:0001927) | 2.18847521 |
| 90 | Abnormality of macrophages (HP:0004311) | 2.18177650 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.18138729 |
| 92 | Patchy hypopigmentation of hair (HP:0011365) | 2.17964033 |
| 93 | Gingival bleeding (HP:0000225) | 2.16575522 |
| 94 | Myositis (HP:0100614) | 2.15650088 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.15500132 |
| 96 | Pulmonary embolism (HP:0002204) | 2.14765231 |
| 97 | Hypoplasia of the thymus (HP:0000778) | 2.12511845 |
| 98 | Abnormality of vitamin B metabolism (HP:0004340) | 2.12169432 |
| 99 | Abnormality of the renal cortex (HP:0011035) | 2.10730037 |
| 100 | Abnormal hemoglobin (HP:0011902) | 2.08294646 |
| 101 | Decreased central vision (HP:0007663) | 2.08148602 |
| 102 | Glomerulonephritis (HP:0000099) | 2.06886470 |
| 103 | Petechiae (HP:0000967) | 2.04550294 |
| 104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03524499 |
| 105 | Recurrent skin infections (HP:0001581) | 2.00793419 |
| 106 | Stomatitis (HP:0010280) | 2.00048515 |
| 107 | Esophageal varix (HP:0002040) | 1.99972384 |
| 108 | Conjunctival telangiectasia (HP:0000524) | 1.99192163 |
| 109 | Hyperbilirubinemia (HP:0002904) | 1.99029245 |
| 110 | True hermaphroditism (HP:0010459) | 1.98966917 |
| 111 | Hepatocellular carcinoma (HP:0001402) | 1.97810041 |
| 112 | Attenuation of retinal blood vessels (HP:0007843) | 1.97302015 |
| 113 | Aortic aneurysm (HP:0004942) | 1.96316026 |
| 114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96078209 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 1.95848985 |
| 116 | Recurrent bronchitis (HP:0002837) | 1.95505131 |
| 117 | Autoimmune hemolytic anemia (HP:0001890) | 1.95397707 |
| 118 | Periodontitis (HP:0000704) | 1.94974450 |
| 119 | Pancreatic fibrosis (HP:0100732) | 1.93509513 |
| 120 | Anorexia (HP:0002039) | 1.92576856 |
| 121 | Glycosuria (HP:0003076) | 1.92337765 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.92337765 |
| 123 | Hypertriglyceridemia (HP:0002155) | 1.92090308 |
| 124 | Chronic diarrhea (HP:0002028) | 1.92011908 |
| 125 | Vascular calcification (HP:0004934) | 1.92010083 |
| 126 | Abnormal ciliary motility (HP:0012262) | 1.91655495 |
| 127 | Pustule (HP:0200039) | 1.91498741 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.91406822 |
| 129 | Panhypogammaglobulinemia (HP:0003139) | 1.91216140 |
| 130 | Pigmentary retinal degeneration (HP:0001146) | 1.90624331 |
| 131 | Bronchiectasis (HP:0002110) | 1.90495072 |
| 132 | Decreased circulating renin level (HP:0003351) | 1.90109181 |
| 133 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89446951 |
| 134 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88957289 |
| 135 | Abnormal cartilage morphology (HP:0002763) | 1.88809836 |
| 136 | Acute hepatic failure (HP:0006554) | 1.88715898 |
| 137 | Alveolar cell carcinoma (HP:0006519) | 1.88237314 |
| 138 | Conjugated hyperbilirubinemia (HP:0002908) | 1.88013800 |
| 139 | Severe combined immunodeficiency (HP:0004430) | 1.87113711 |
| 140 | Retrobulbar optic neuritis (HP:0100654) | 1.86476072 |
| 141 | Optic neuritis (HP:0100653) | 1.86476072 |
| 142 | B lymphocytopenia (HP:0010976) | 1.86096765 |
| 143 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.85694263 |
| 144 | Osteolytic defects of the hand bones (HP:0009699) | 1.85694263 |
| 145 | Metabolic acidosis (HP:0001942) | 1.84946955 |
| 146 | Increased CSF protein (HP:0002922) | 1.84809276 |
| 147 | Abnormality of nucleobase metabolism (HP:0010932) | 1.84666367 |
| 148 | Urticaria (HP:0001025) | 1.84575455 |
| 149 | Disproportionate short-trunk short stature (HP:0003521) | 1.84455128 |
| 150 | Hyperglycemia (HP:0003074) | 1.83678268 |
| 151 | Rhinitis (HP:0012384) | 1.83032148 |
| 152 | Orchitis (HP:0100796) | 1.82008748 |
| 153 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.81923963 |
| 154 | Spontaneous hematomas (HP:0007420) | 1.81241191 |
| 155 | Pulmonary infiltrates (HP:0002113) | 1.81179729 |
| 156 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.80780916 |
| 157 | Cardiovascular calcification (HP:0011915) | 1.79683751 |
| 158 | Toxemia of pregnancy (HP:0100603) | 1.78618082 |
| 159 | Asplenia (HP:0001746) | 1.78540369 |
| 160 | Tetraparesis (HP:0002273) | 1.78382156 |
| 161 | Abnormality of T cell number (HP:0011839) | 1.78351111 |
| 162 | Nasal polyposis (HP:0100582) | 1.78116275 |
| 163 | Thrombocytosis (HP:0001894) | 1.78099533 |
| 164 | Hepatosplenomegaly (HP:0001433) | 1.77888907 |
| 165 | Facial diplegia (HP:0001349) | 1.76784821 |
| 166 | Hyperglycinemia (HP:0002154) | 1.76151384 |
| 167 | Curly hair (HP:0002212) | 1.76050069 |
| 168 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.74325303 |
| 169 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74297620 |
| 170 | Pendular nystagmus (HP:0012043) | 1.74223348 |
| 171 | Nephritis (HP:0000123) | 1.73578795 |
| 172 | Thrombophlebitis (HP:0004418) | 1.72485927 |
| 173 | Increased cerebral lipofuscin (HP:0011813) | 1.72095675 |
| 174 | Syringomyelia (HP:0003396) | 1.71894036 |
| 175 | Spinal cord lesions (HP:0100561) | 1.71894036 |
| 176 | Hemorrhage of the eye (HP:0011885) | 1.71752570 |
| 177 | Interstitial pulmonary disease (HP:0006530) | 1.71659890 |
| 178 | Axonal loss (HP:0003447) | 1.70404296 |
| 179 | Abnormality of the nasal mucosa (HP:0000433) | 1.69749231 |
| 180 | Elevated hepatic transaminases (HP:0002910) | 1.68729972 |
| 181 | Epistaxis (HP:0000421) | 1.66972915 |
| 182 | Nonimmune hydrops fetalis (HP:0001790) | 1.66641094 |
| 183 | Recurrent fungal infections (HP:0002841) | 1.65630499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 3.56763992 |
| 2 | AKT3 | 3.52987127 |
| 3 | MAP3K14 | 2.83453560 |
| 4 | TAF1 | 2.68677380 |
| 5 | NEK9 | 2.49691467 |
| 6 | ERN1 | 2.48387795 |
| 7 | TYK2 | 2.46114105 |
| 8 | BCKDK | 2.41151675 |
| 9 | TNIK | 2.26641361 |
| 10 | TAOK3 | 2.15239424 |
| 11 | NME2 | 2.12869143 |
| 12 | MST4 | 2.10187450 |
| 13 | TBK1 | 2.07067818 |
| 14 | IRAK3 | 1.97983853 |
| 15 | PBK | 1.94764915 |
| 16 | IRAK4 | 1.91588737 |
| 17 | TEC | 1.86323651 |
| 18 | JAK3 | 1.83154953 |
| 19 | MAP4K1 | 1.70092805 |
| 20 | FGFR4 | 1.69797744 |
| 21 | FLT3 | 1.69445901 |
| 22 | IKBKE | 1.66906348 |
| 23 | RPS6KA4 | 1.56223602 |
| 24 | PIK3CG | 1.52622291 |
| 25 | PIM2 | 1.51103942 |
| 26 | TGFBR2 | 1.48422222 |
| 27 | JAK1 | 1.47928651 |
| 28 | TRPM7 | 1.45411631 |
| 29 | MAPK15 | 1.42809900 |
| 30 | NUAK1 | 1.40509155 |
| 31 | STK10 | 1.39485795 |
| 32 | LATS1 | 1.38063799 |
| 33 | EPHB1 | 1.36073751 |
| 34 | ILK | 1.36044463 |
| 35 | MAP3K3 | 1.36011527 |
| 36 | FRK | 1.34905030 |
| 37 | SGK2 | 1.34054979 |
| 38 | TXK | 1.33950588 |
| 39 | MST1R | 1.33230422 |
| 40 | ZAP70 | 1.32752279 |
| 41 | NLK | 1.29890129 |
| 42 | MAP3K12 | 1.29797871 |
| 43 | KIT | 1.28534994 |
| 44 | STK3 | 1.24808440 |
| 45 | IKBKB | 1.24080832 |
| 46 | STK24 | 1.21612962 |
| 47 | CSK | 1.19968787 |
| 48 | FGR | 1.15821398 |
| 49 | BTK | 1.15618392 |
| 50 | SIK1 | 1.14658869 |
| 51 | ITK | 1.12617997 |
| 52 | LMTK2 | 1.08597635 |
| 53 | CHUK | 1.08248240 |
| 54 | GRK7 | 1.08041482 |
| 55 | TRIB3 | 1.05419309 |
| 56 | LRRK2 | 1.04140427 |
| 57 | PRKCE | 1.01978870 |
| 58 | MAP4K2 | 1.00381384 |
| 59 | INSRR | 0.99888529 |
| 60 | EPHA3 | 0.99285474 |
| 61 | WNK3 | 0.97374171 |
| 62 | GRK6 | 0.95175482 |
| 63 | MUSK | 0.94268717 |
| 64 | CDK6 | 0.94244930 |
| 65 | MAP2K3 | 0.92974079 |
| 66 | BLK | 0.91939053 |
| 67 | PINK1 | 0.91405401 |
| 68 | GRK1 | 0.89899888 |
| 69 | PIM1 | 0.88605243 |
| 70 | TESK1 | 0.88209572 |
| 71 | EIF2AK3 | 0.87102076 |
| 72 | KDR | 0.85589474 |
| 73 | PRKD2 | 0.83046527 |
| 74 | ADRBK1 | 0.82875996 |
| 75 | JAK2 | 0.82237810 |
| 76 | MAP3K13 | 0.82031034 |
| 77 | TAOK1 | 0.81181663 |
| 78 | IRAK1 | 0.80917817 |
| 79 | STK4 | 0.79775621 |
| 80 | PAK3 | 0.79509142 |
| 81 | ABL2 | 0.79359237 |
| 82 | PTK6 | 0.78898931 |
| 83 | PKN2 | 0.78348013 |
| 84 | HIPK2 | 0.77552552 |
| 85 | TGFBR1 | 0.75071980 |
| 86 | SGK223 | 0.73982287 |
| 87 | SGK494 | 0.73982287 |
| 88 | CAMK1D | 0.72701369 |
| 89 | SIK3 | 0.72347572 |
| 90 | DYRK1B | 0.72035167 |
| 91 | CSF1R | 0.71559889 |
| 92 | PTK2 | 0.70598539 |
| 93 | SGK3 | 0.69451655 |
| 94 | WNK4 | 0.69406796 |
| 95 | BMPR1B | 0.68587330 |
| 96 | MOS | 0.67232717 |
| 97 | PRKAA2 | 0.67050739 |
| 98 | ERBB3 | 0.66799284 |
| 99 | FGFR3 | 0.66357189 |
| 100 | PDK2 | 0.65526394 |
| 101 | ROCK1 | 0.64880532 |
| 102 | STK38L | 0.64386762 |
| 103 | MATK | 0.64330480 |
| 104 | CDK9 | 0.63371832 |
| 105 | LCK | 0.62820634 |
| 106 | MAPKAPK3 | 0.62627764 |
| 107 | BRSK2 | 0.62475466 |
| 108 | MYLK | 0.61814173 |
| 109 | MAPKAPK2 | 0.61023491 |
| 110 | EIF2AK2 | 0.59998996 |
| 111 | TNK2 | 0.59496928 |
| 112 | RIPK1 | 0.59491085 |
| 113 | EPHB2 | 0.59262288 |
| 114 | MAPK11 | 0.59257638 |
| 115 | ADRBK2 | 0.59167081 |
| 116 | PRKG2 | 0.58228516 |
| 117 | PTK2B | 0.58079398 |
| 118 | RIPK4 | 0.57674097 |
| 119 | MARK3 | 0.57027293 |
| 120 | FES | 0.56667498 |
| 121 | TIE1 | 0.56005908 |
| 122 | ABL1 | 0.55902609 |
| 123 | TRIM28 | 0.55264436 |
| 124 | TESK2 | 0.54643261 |
| 125 | MET | 0.54504849 |
| 126 | HCK | 0.53358479 |
| 127 | LYN | 0.51858949 |
| 128 | FGFR2 | 0.51708055 |
| 129 | YES1 | 0.50796766 |
| 130 | PLK2 | 0.49652789 |
| 131 | DDR2 | 0.49531367 |
| 132 | PIK3CA | 0.49392033 |
| 133 | IGF1R | 0.48704791 |
| 134 | ZAK | 0.46571264 |
| 135 | RPS6KA5 | 0.46100738 |
| 136 | MAP2K6 | 0.45588451 |
| 137 | CAMK2D | 0.44806923 |
| 138 | MAPK13 | 0.44650410 |
| 139 | PDK4 | 0.44043599 |
| 140 | PDK3 | 0.44043599 |
| 141 | PRKCQ | 0.43879764 |
| 142 | OBSCN | 0.43580602 |
| 143 | BMPR2 | 0.42774265 |
| 144 | PRKD1 | 0.42262823 |
| 145 | PRKG1 | 0.42219221 |
| 146 | SYK | 0.41499532 |
| 147 | FER | 0.40493487 |
| 148 | STK11 | 0.39488288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.70419171 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.53874997 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46362799 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40843426 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23118338 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.11859567 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.06365388 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06151154 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04564445 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 2.01902092 |
| 11 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.96490673 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95287711 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94949350 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91855266 |
| 15 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.89951913 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89076956 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.86687136 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76335192 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.75160348 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.70815956 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.69995113 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67608545 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65261882 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64443671 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.61319937 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52881360 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.52241799 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46621478 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46146362 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40518838 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39119612 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37983878 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35248407 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.27757251 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25817274 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25201368 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24475578 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.23513317 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23325275 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22522879 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21674515 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.21216295 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18683619 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.17150905 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16060317 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.13371497 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10669189 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09473513 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07042168 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04423782 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98771599 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97622847 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97463243 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97307806 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95620614 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95380201 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94963852 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.93310215 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93045913 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92090947 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91511850 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89566436 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89139415 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88767507 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88686022 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87891701 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.87185707 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86315530 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84764323 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84327538 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82430764 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81853586 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81055658 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.80834368 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80759336 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.79644231 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.78982720 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75782135 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72964316 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72464793 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.72329129 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.69125208 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67963621 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67832767 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66867980 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66857391 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66734469 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65933479 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.65772720 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.65583186 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65359293 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65298788 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64858014 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64219810 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.63712475 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63358169 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.62718714 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.62201076 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62174958 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62059045 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61281731 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60150662 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59532199 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58842558 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58639751 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.58300911 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56702174 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55787312 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55694600 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55366356 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54481472 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53253389 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53208063 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50857053 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.50657001 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49450903 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48986364 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48622143 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48010954 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47319508 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.46983087 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46128569 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46084267 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.45537380 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.44912855 |
| 126 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44521857 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42095355 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41717078 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41072798 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.40972174 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40576945 |
| 132 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39680034 |
| 133 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36445784 |

